Related references
Note: Only part of the references are listed.Depression, cytokines, and pancreatic cancer
William Breitbart et al.
PSYCHO-ONCOLOGY (2014)
Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients
Masatoshi Inagaki et al.
SUPPORTIVE CARE IN CANCER (2013)
Dopaminergic Mechanisms of Reduced Basal Ganglia Responses to Hedonic Reward During Interferon Alfa Administration
Lucile Capuron et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: A meta-analysis and meta-regression
Yang Liu et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Evidence-Based Treatment of Depression in Patients With Cancer
Madeline Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies
Alex J. Mitchell et al.
LANCET ONCOLOGY (2011)
Emerging tendency towards autoimmune process in major depressive patients: A novel insight from Th17 cells
Yili Chen et al.
PSYCHIATRY RESEARCH (2011)
A Meta-Analysis of Cytokines in Major Depression
Yekta Dowlati et al.
BIOLOGICAL PSYCHIATRY (2010)
To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markers
Mary-Frances O'Connor et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals?
Lucile Capuron et al.
JOURNAL OF AFFECTIVE DISORDERS (2009)
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
M. Bryant Howren et al.
PSYCHOSOMATIC MEDICINE (2009)
Measuring Depression at the End of Life Is the Hamilton Depression Rating Scale a Valid Instrument?
Megan Olden et al.
ASSESSMENT (2009)
The GRID-HAMD: standardization of the Hamilton depression rating scale
Janet B. W. Williams et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients
Susan K. Lutgendorf et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer
Andrew H. Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Differences in depressive thoughts between major depressive disorder, IFN-α-induced depression, and depressive disorders among cancer patients
Massimo Pasquini et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2008)
The phenomenology and screening of clinical depression in cancer patients
Derek R. Hopko et al.
JOURNAL OF PSYCHOSOCIAL ONCOLOGY (2008)
Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis
Robert E. Iosif et al.
JOURNAL OF NEUROSCIENCE (2006)
Lower hippocampal volume in patients suffering from depression: A meta-analysis
S Campbell et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Neurobehavioral effects of interferon-α in cancer patients:: Phenomenology and paroxetine responsiveness of symptom dimensions
L Capuron et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Paroxetine for the prevention of depression induced by high-dose interferon alfa
DL Musselman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
